HomeANTX • NASDAQ
add
AN2 Therapeutics Inc
Previous close
$1.30
Day range
$1.24 - $1.29
Year range
$0.87 - $22.13
Market cap
37.35M USD
Avg Volume
274.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.77M | -35.25% |
Net income | -12.75M | 23.70% |
Net profit margin | — | — |
Earnings per share | -0.35 | 45.85% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 93.43M | -24.55% |
Total assets | 97.69M | -36.49% |
Total liabilities | 10.02M | -32.50% |
Total equity | 87.67M | — |
Shares outstanding | 29.88M | — |
Price to book | 0.44 | — |
Return on assets | -28.55% | — |
Return on capital | -31.64% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.75M | 23.70% |
Cash from operations | -12.01M | -1.75% |
Cash from investing | 18.72M | 129.97% |
Cash from financing | 23.00K | -99.97% |
Net change in cash | 6.74M | 182.17% |
Free cash flow | -6.93M | -34.68% |
About
Founded
2017
Headquarters
Website
Employees
41
